Candel Therapeutics (CADL) Shares Outstanding (Diluted) (2021 - 2026)
Candel Therapeutics (CADL) reported Weighted Average Shares Outstanding (Diluted) of 74.13 million for Q2 2026, up 44.0% from 51.49 million a year earlier.
Powered by 
Analysis
Candel Therapeutics (CADL) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
For FY2025, Candel Therapeutics posted Weighted Average Shares Outstanding (Diluted) of 52.96 million, up 67.2% from FY2024.
- Weighted Average Shares Outstanding (Diluted) has increased for four consecutive years, with a four-year compound annual growth rate of 29.4% (FY2021 to FY2025).
- By year, Weighted Average Shares Outstanding (Diluted) came in at 31.68 million in FY2024 (+9.5%), 28.94 million in FY2023 (+0.4%), 28.82 million in FY2022 (+52.7%) and 18.87 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to Q2 2021.
- Over the past five years, the year-over-year growth in Weighted Average Shares Outstanding (Diluted) ranged from 0.1% (Q3 2023) to 145.8% (Q2 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Candel Therapeutics | 711.71 Mn | 108.61 Mn | - | 74.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 74.13 Mn |
| Mar 31, 2026 | 62.36 Mn |
| Dec 31, 2025 | 52.96 Mn |
| Sep 30, 2025 | 54.89 Mn |
| Jun 30, 2025 | 51.49 Mn |
| Mar 31, 2025 | 54.77 Mn |
| Dec 31, 2024 | 31.68 Mn |
| Sep 30, 2024 | 32.01 Mn |
| Jun 30, 2024 | 29.88 Mn |
| Mar 31, 2024 | 29.20 Mn |
| Dec 31, 2023 | 28.94 Mn |
| Sep 30, 2023 | 28.92 Mn |
| Jun 30, 2023 | 28.92 Mn |
| Mar 31, 2023 | 28.92 Mn |
| Dec 31, 2022 | 28.82 Mn |
| Sep 30, 2022 | 28.89 Mn |
| Jun 30, 2022 | 28.81 Mn |
| Mar 31, 2022 | 28.69 Mn |
| Dec 31, 2021 | 18.87 Mn |
| Sep 30, 2021 | 23.33 Mn |
API Access
Candel Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CADL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "CADL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CADL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();